GALNT14 and hepatocellular carcinoma: In HCC cells overexpressing GALNT14, only PHB2 with the Ser161Ala point mutation attenuated its ability to bind either VVA or PNA, but not the Thr288Ala or Ser291Ala substitutions (Fig. 4B).